CEDARHURST, N.Y., Feb. 24, 2019 (GLOBE NEWSWIRE) -- The securities litigation law firm of Kuznicki Law PLLC issues
the following notice on behalf of shareholders of the following publicly traded companies. Shareholders who purchased shares in
these companies during the dates listed below are encouraged to contact the firm regarding possible appointment as lead plaintiff
and a preliminary estimate of their recoverable losses.
If you wish to choose counsel to represent you and the class, you must apply to be appointed lead plaintiff and be selected by
the Court. The lead plaintiff will direct the litigation and participate in important decisions including whether to accept a
settlement for the class in the action. The lead plaintiff will be selected from among applicants claiming the largest loss from
investment in the respective securities during the class periods. Members of the class will be represented by the lead plaintiff
and counsel chosen by the lead plaintiff. No classes have yet been certified in the actions below. Appointment as lead plaintiff is
not required to partake in any recovery.
AxoGen, Inc. (NASDAQ: AXGN)
Investors Affected: August 7, 2017 - December 18, 2018
A class action has commenced on behalf of certain shareholders in AxoGen, Inc. The filed complaint alleges that defendants made
materially false and/or misleading statements and/or failed to disclose that: (1) the Company aggressively increased prices to mask
lower sales; (2) the Company’s pricing alienated customers and threatened the Company’s future growth; (3) ambulatory surgery
centers form a significant part of the market for the Company’s products; (4) such centers were especially sensitive to price
increases; (5) the Company was dependent on a small number of surgeons whom the Company paid to generate sales; (6) the Company’s
consignment model for inventory was reasonably likely to lead to channel stuffing; (7) the Company offered purchase incentives to
sales representatives to encourage channel stuffing; (8) the Company’s sales representatives were encouraged to backdate revenue to
artificially inflate metrics; (9) the Company lacked adequate internal controls to prevent such channel stuffing and backdating of
revenue; (10) the Company’s key operating metrics, such as number of active accounts, were overstated; and (11) as a result of the
foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects, were materially misleading
and/or lacked a reasonable basis.
Shareholders may find more information at https://kseclaw.com/securities/axogen-inc/?wire=3
DXC Technology Company (NYSE: DXC)
Investors Affected: February 8, 2018 - November 6, 2018
A class action has commenced on behalf of certain shareholders in DXC Technology Company. The filed complaint alleges that
defendants made materially false and/or misleading statements and/or failed to disclose that: (a) the Company had changed or
planned to change the operations of its sales teams, deploying generalized sales teams as opposed to the specialized teams that
were better capable of delivering specialized services to its clients; (b) the Company’s workforce optimization strategy of sharply
reducing staff while reducing costs was resulting in a shortage of sales personnel who could execute on demand for services,
thereby risking and ultimately losing sales and revenue opportunities; (c) in light of the above, the Company’s revenue and
financial performance guidance for the fiscal year 2019 and its reaffirmation of the guidance during the Class Period was without a
reasonable basis.
Shareholders may find more information at https://kseclaw.com/securities/dxc-technology-company/?wire=3
Maxar Technologies Inc. (NYSE: MAXR)
Investors Affected: March 29, 2018 - January 7, 2019
A class action has commenced on behalf of certain shareholders in Maxar Technologies Inc. The filed complaint alleges that
defendants made materially false and/or misleading statements and/or failed to disclose that: (i) Maxar improperly inflated the
value of its intangible assets, among other accounting improprieties; (ii) Maxar’s highly-valued WorldView-4 was equipped with CMGs
that were faulty and/or ill-suited for their designed and intended purpose; and (iii) as a result, Maxar’s public statements were
materially false and misleading at all relevant times.
Shareholders may find more information at https://kseclaw.com/securities/maxar-technologies-inc/?wire=3
Bristow Group Inc. (NYSE: BRS)
Investors Affected: February 8, 2018 - February 12, 2019
A class action has commenced on behalf of certain shareholders in Bristow Group Inc. The filed complaint alleges that defendants
made materially false and/or misleading statements and/or failed to disclose that: (1) Bristow lacked adequate monitoring processes
related to non-financial covenants within its secured financing and lease agreements; (2) Bristow could not reasonably assure
compliance with certain non-financial covenants; (3) Bristow was reasonably likely to breach certain agreements; (4) Bristow had
understated its short-term debt; (5) the required corrections would materially impact financial statements; (6) there was a
material weakness in Bristow’s internal controls over financial reporting; and (7) as a result of the foregoing, defendants’
positive statements about Bristow’s business, operations, and prospects were materially misleading and/or lacked a reasonable
basis.
Shareholders may find more information at https://kclasslaw.com/securities/bristow-group-inc-loss-submission-form/?wire=3
Kuznicki Law PLLC is committed to ensuring that companies adhere to responsible business practices and engage in
good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading
statements or the omission of material information by a Company lead to artificial inflation of the Company's stock.
CONTACT:
Kuznicki Law PLLC
Daniel Kuznicki, Esq.
445 Central Avenue, Suite 334
Cedarhurst, NY 11516
Email: dk@kclasslaw.com
Phone: (347) 696-1134
Cell: (347) 690-0692
Fax: (347) 348-0967
